Photo from Tom Powles/Twitter
Oct 25, 2023, 17:27
Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system
Tom Powles, Director of Barts Cancer Centre, shared on Twitter:
”Something NEW. TAR-210 releases Erdafitinib slowly into the bladder by a novel release system. In BCG refractory FGFR selected High risk NMIBC 82-87% of patients were recurrent free at 1st cut off in the 2 cohort. This could have a major impact in NMIBC and MIBC.”
Source: Tom Powles/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 21:21
Dec 23, 2024, 21:19
Dec 23, 2024, 21:16
Dec 23, 2024, 21:09
Dec 23, 2024, 20:37
Dec 23, 2024, 20:18
Dec 23, 2024, 20:14